Latest news
Explicating the Status of ctDNA MRD Testing in the MIBC Treatment Paradigm - CancerNetworkCancerNetwork · Thu, 06 Aug 2026 18:14:44 GMTNavigating Reimbursement and Timing in Postoperative ctDNA Testing for MIBC - CancerNetworkCancerNetwork · Thu, 06 Aug 2026 14:09:37 GMTNCCN Guidelines: Navigating ctDNA MRD Testing in Evolving MIBC Paradigms - CancerNetworkCancerNetwork · Wed, 05 Aug 2026 18:04:30 GMTNavigating ctDNA-Guided Decision-Making in Muscle-Invasive Bladder Cancer - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 22:09:15 GMTSubcutaneous Amivantamab Receives FDA Priority Review in R/M HNSCC - CancerNetworkCancerNetwork · Fri, 31 Jul 2026 17:08:12 GMTFrom Blunt Instruments to Molecular Precision: 40 Years of Oncology Evolution - CancerNetworkCancerNetwork · Thu, 30 Jul 2026 02:16:33 GMTCretostimogene Grenadenorepvec Shows Complete Responses in NMIBC - CancerNetworkCancerNetwork · Tue, 28 Jul 2026 17:08:36 GMT